A commitment to end breast cancer through research
Laboratory scientists welcomed Vera Bradley Foundation staff and volunteers to the Vera Bradley Foundation for Breast Cancer Research Laboratories. They hosted a town hall meeting and described how Vera Bradley Foundation-funded research is transforming patient care in Indiana and beyond.
Having lost a dear friend to breast cancer, Vera Bradley founders Patricia R. Miller and Barbara B. Baekgaard visited the IU Simon Cancer Center to learn about its breast cancer research program. Flowers were on the conference room table and the lead researcher was instructed to wear a tie that day. But it wasn’t the spit-polished environment that impressed Pat and Barb. It was the sheer passion and shared energy for curing breast cancer by all at the table that compelled them to invest in the program.
That was in 1999 when the breast cancer program at IU consisted of six researchers. Since then, the Vera Bradley Foundation for Breast Cancer has generated nearly $25 million in research funding for the IU Simon Cancer Center with an additional $10 million pledged. Vera Bradley Foundation generosity has resulted in a critical mass of more than 30 researchers now working together, reflecting the complexity of the disease and the diverse expertise needed to help women live breast cancer free.
Drs. Miller and Schneider thank Vera Bradley.
Vera Bradley Chair in Breast Cancer Research established and the inaugural chair holder is recruited. The goal of the chair is to attract a highly impactful researcher to propel the laboratory program forward.
Fund established to launch the biomarker discovery program to develop targeted treatments and to increase by six fold the number of breast cancer researchers at Indiana University (total of $18.8 million committed).
Opening of the new Vera Bradley Foundation for Breast Cancer Research Laboratories at IU.
Bryan Schneider, M.D., is named the new Vera Bradley Chair holder.
Launch of Monogrammed Medicine research program. The program seeks to tailor treatments based on the genomics of each woman and her cancer.
Launch of Vera Bradley Scholars Program.
Two additional Vera Bradley Foundation chairs established ($2 million).
Monogrammed Medicine patients are screened to determine their risk for painful side effects of chemotherapy.